CAMELLIA: Anti-CD47 Antibody Therapy in Haematological Malignancies

Clinical trial NCT02678338 · COMPLETED

Trial details

NCT number: NCT02678338
Sponsor: Gilead Sciences
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Acute Myeloid Leukemia Myelodysplastic Syndrome

Start date: 2015-11-01
Primary completion: 2018-11-01
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.